Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,685 | 105,596 | 187,665 | 298,172 | 418,538 |
| Marketable Securities | 62,318 | 61,855 | 53,598 | 29,312 | 68,294 |
| Receivables | 17,057 | 15,796 | 12,270 | 16,785 | 14,114 |
| Other current assets | 1,634 | 979 | 1,524 | 1,513 | 2,645 |
| TOTAL | $161,690 | $192,003 | $261,338 | $353,464 | $511,718 |
| Non-Current Assets | |||||
| PPE Net | 9,288 | 9,553 | 12,103 | 11,875 | 11,884 |
| Investments And Advances | 0 | 0 | 18,776 | 0 | 0 |
| Other Non-Current Assets | 242,612 | 245,074 | 246,333 | 242,061 | 239,894 |
| TOTAL | $251,900 | $254,627 | $277,212 | $253,936 | $251,778 |
| Total Assets | $413,590 | $446,630 | $538,550 | $607,400 | $763,496 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,368 | 1,569 | 2,663 | 1,554 | 5,337 |
| Accrued Expenses | 8,481 | 8,245 | 9,616 | 14,334 | 11,309 |
| TOTAL | $25,368 | $24,546 | $26,184 | $28,715 | $142,132 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 24 | 24 | 24 | N/A | 24 |
| Other Non-Current Liabilities | 141,917 | 141,742 | 141,620 | 136,693 | 140,587 |
| TOTAL | $142,092 | $141,923 | $141,807 | $136,885 | $140,786 |
| Total Liabilities | $167,460 | $166,469 | $167,991 | $165,600 | $282,918 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,798 | 52,813 | 57,797 | 62,864 | 67,366 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -900,594 | -891,644 | -875,999 | -853,911 | -843,549 |
| Other shareholders' equity | -225 | -286 | 51 | -15 | -121 |
| TOTAL | $246,130 | $280,161 | $370,559 | $441,800 | $480,578 |
| Total Liabilities And Equity | $413,590 | $446,630 | $538,550 | $607,400 | $763,496 |